版本:
中国

BRIEF-Adaptimmune Therapeutics Plc announces initiation of triple tumor study

Oct 18 Adaptimmune Therapeutics Plc :

* Adaptimmune Therapeutics Plc - adaptimmune announces initiation of triple tumor study to evaluate its spear t-cell therapy targeting MAGE-A10 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐